US drugmakers hit with penalties for high prices

Dozens of pharmaceutical companies in the US are being hit with penalties for charging prices deemed too high by the Biden administration. The White House says these ‘inflation rebates’ will reduce medication costs for the most vulnerable in society. Our correspondent Benji Hyer reports.